Recent Progress of Tertiary Lymphoid Structure in Prognosis and Immunotherapy of Non-small Cell Lung Cancer
Lung cancer is the leading cause of cancer death, and non-small cell lung cancer (NSCLC) accounts for 85%. Immunotherapy has significantly improved the clinical prognosis of patients with NSCLC. However, because of the complexity and heterogeneousness of the tumor microenvironment, only a subset of...
Main Authors: | Ying LIU, Lei XIONG, Ruoxue CAI, Yue CHEN, Jinjun YE, Bo SHEN, Guoren ZHOU |
---|---|
Format: | Article |
Language: | zho |
Published: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2023-08-01
|
Series: | Chinese Journal of Lung Cancer |
Subjects: | |
Online Access: | http://dx.doi.org/10.3779/j.issn.1009-3419.2023.101.23 |
Similar Items
-
Tertiary lymphoid structures and B lymphocytes in cancer prognosis and response to immunotherapies
by: Jacquelot N, et al.
Published: (2021-01-01) -
The gene signature of tertiary lymphoid structures within ovarian cancer predicts the prognosis and immunotherapy benefit
by: Yue Hou, et al.
Published: (2023-01-01) -
Tertiary lymphoid structures in pancreatic cancer: a new target for immunotherapy
by: Xinlei Zou, et al.
Published: (2023-07-01) -
Tertiary Lymphoid Structures as Mediators of Immunotherapy Response
by: Raj G. Vaghjiani, et al.
Published: (2022-08-01) -
Inducible Tertiary Lymphoid Structures: Promise and Challenges for Translating a New Class of Immunotherapy
by: Shota Aoyama, et al.
Published: (2021-05-01)